$0.50
12.50% yesterday
Nasdaq, May 16, 10:18 pm CET
ISIN
US88688T1007
Symbol
TLRY
Sector
Industry

Tilray, Inc. Series 2 Stock price

$0.50
+0.02 4.04% 1M
-0.83 62.50% 6M
-0.84 62.78% YTD
-1.63 76.65% 1Y
-4.39 89.86% 3Y
-7.47 93.78% 5Y
-21.90 97.79% 10Y
Nasdaq, Closing price Fri, May 16 2025
+0.06 12.50%
ISIN
US88688T1007
Symbol
TLRY
Sector
Industry

Key metrics

Market capitalization $451.23m
Enterprise Value $519.06m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.63
P/S ratio (TTM) P/S ratio 0.55
P/B ratio (TTM) P/B ratio 0.16
Revenue growth (TTM) Revenue growth 11.22%
Revenue (TTM) Revenue $826.66m
EBIT (operating result TTM) EBIT $-115.75m
Free Cash Flow (TTM) Free Cash Flow $-83.47m
Cash position $248.41m
EPS (TTM) EPS $-1.05
P/E forward negative
P/S forward 0.53
EV/Sales forward 0.61
Short interest 17.39%
Show more

Is Tilray, Inc. Series 2 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,785 stocks worldwide.

Tilray, Inc. Series 2 Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Tilray, Inc. Series 2 forecast:

4x Buy
33%
8x Hold
67%

Analyst Opinions

12 Analysts have issued a Tilray, Inc. Series 2 forecast:

Buy
33%
Hold
67%

Financial data from Tilray, Inc. Series 2

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Feb '25
+/-
%
827 827
-
100%
- Direct Costs 658 658
-
80%
168 168
-
20%
- Selling and Administrative Expenses 152 152
-
18%
- Research and Development Expense 0.64 0.64
-
0%
15 15
-
2%
- Depreciation and Amortization 131 131
-
16%
EBIT (Operating Income) EBIT -116 -116
-
-14%
Net Profit -946 -946
-
-114%

In millions USD.

Don't miss a Thing! We will send you all news about Tilray, Inc. Series 2 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tilray, Inc. Series 2 Stock News

Neutral
GlobeNewsWire
2 days ago
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, is excited to announce that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours, a new line of cannabis beverages and gummies that redefine the sour experience.
Positive
MarijuanaStocks
3 days ago
The U.S. cannabis industry continues to surge, reaching an estimated $45 billion in 2025. Analysts expect it to grow to over $75 billion by 2030. With federal reform discussions advancing and legalization expanding, Canadian cannabis companies are positioning for growth. Many are making strategic moves to increase their U.S. exposure through acquisitions and partnerships.
Neutral
The Motley Fool
4 days ago
Fundamental investing wisdom tells us to buy stocks with potential when they are trading at a lower valuation. But when a company's prospects look dim, its stock isn't going to be attractive even when trading near its 52-week low.
More Tilray, Inc. Series 2 News

Company Profile

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

Head office United States
CEO Irwin Simon
Employees 2,650
Founded 2018
Website www.tilray.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today